Short-term treatment with bromocriptine improves impaired circadian growth hormone secretion in obese premenopausal women

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 9, 2008, Pages 3455-3461

  Kok, Petra ^a   Roelfsema, Ferdinand ^a   Frölich, Marijke ^a   Van Pelt, Johannes ^a   Meinders, A Edo ^a   Pijl, Hanno ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BROMOCRIPTINE; DOPAMINE; DOPAMINE 2 RECEPTOR STIMULATING AGENT; GROWTH HORMONE; PLACEBO; SOMATOMEDIN C;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOPAMINERGIC SYSTEM; DRUG RESPONSE; FEMALE; FOLLICULAR PHASE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HUMAN; NAUSEA; NEUROPATHOLOGY; OBESITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SHORT COURSE THERAPY; TREATMENT OUTCOME; VOMITING;

EID: 51649089664     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-0001     Document Type: Article

References (62)

1. Veldhuis JD, Iranmanesh A, Ho KK, Waters MJ, Johnson ML, Lizarralde G 1991 Dual defects in pulsatile growth hormone secretion and clearance subserve the hyposomatotropism of obesity in man. J Clin Endocrinol Metab 72:51-59
2. Iranmanesh A, Lizarralde G, Veldhuis JD 1991 Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone(GH) secretory bursts and the half-life of endogenous GH in healthy men. J Clin Endocrinol Metab 73:1081-1088
3. DeMarinis L, Mancini A, Zuppi P, Calabro F, Fiumara C, Lagonigro G, Fabrizi ML, Sammartano L 1992 Influence of pyridostigmine on growth hormone (GH) response to GH-releasing hormone pre- and postprandially in normal and obese subjects. J Clin Endocrinol Metab 74:1253-1257
4. Cordido F, Penalva A, Dieguez C, Casanueva FF 1993 Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity. J Clin Endocrinol Metab 76:819-823
5. Van Cauter EV, Polonsky KS, Blackman JD, Roland D, Sturis J, Byrne MM, Scheen AJ 1994 Abnormal temporal patterns of glucose tolerance in obesity: relationship to sleep-related growth hormone secretion and circadian cortisol rhythmicity. J Clin Endocrinol Metab 79:1797-1805
6. Rasmussen MH, Juul A, Kjems LL, Skakkebaek NE, Hilsted J 1995 Lack of stimulation of 24-hour growth hormone release by hypocaloric diet in obesity. J Clin Endocrinol Metab 80:796-801
7. Veldhuis JD, Liem AY, South S, Weltman A, Weltman J, Clemmons DA, Abbott R, Mulligan T, Johnson ML, Pincus S 1995 Differential impact of age, sex steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay. J Clin Endocrinol Metab 80:3209-3222
8. Kirk SE, Gertz BJ, Schneider SH, Hartman ML, Pezzoli SS, Wittreich JM, Krupa DA, Seibold JR, Thorner MO 1997 Effect of obesity and feeding on the growth hormone (GH) response to the GH secretagogue L-692,429 in young men. J Clin Endocrinol Metab 82:1154-1159
9. Kanaley JA, Weatherup-Dentes MM, Jaynes EB, Hartman ML 1999 Obesity attenuates the growth hormone response to exercise. J Clin Endocrinol Metab 84:3156-3161
10. Pijl H, Langendonk JG, Burggraaf J, Frolich M, Cohen AF, Veldhuis JD, Meinders AE 2001 Altered neuroregulation of GH secretion in viscerally obese premenopausal women. J Clin Endocrinol Metab 86:5509-5515
11. Miell JP, Pralong FP, Corder R, Gaillard RC 1990 Stimulation of growth hormone release in man by the potent D2-dopamine agonist CV 205-502: comparison of responses to intravenous and oral administration. J Clin Endocrinol Metab 71:1519-1524
12. Vance ML, Kaiser DL, Frohman LA, Rivier J, Vale WW, Thorner MO 1987 Role of dopamine in the regulation of growth hormone secretion: dopamine and bromocriptine augment growth hormone (GH)-releasing hormone-stimulated GH secretion in normal man. J Clin Endocrinol Metab 64:1136-1141
13. Bansal SA, Lee LA, Woolf PD 1981 Dopaminergic stimulation and inhibition of growth hormone secretion in normal man: studies of the pharmacologic specificity. J Clin Endocrinol Metab 53:1273-1277
14. Kaptein EM, Kletzky OA, Spencer CA, Nicoloff JT 1980 Effects of prolonged dopamine infusion on anterior pituitary function in normal males. J Clin Endocrinol Metab 51:488-491
15. Camanni F, Massara F, Belforte L, Rosatello A, Molinatti GM 1977 Effect of dopamine on plasma growth hormone and prolactin levels in normal and acromegalic subjects. J Clin Endocrinol Metab 44:465-473
16. Bellastella A, Colucci CF, D'Alessandro B, Lo Cicero M 1977 L-Dopa stimulated growth hormone release in the blind. J Clin Endocrinol Metab 44:194-195
17. Diaz-Torga G, Feierstein C, Libertun C, Gelman D, Kelly MA, Low MJ, Rubinstein M, Becu-Villalobos D 2002 Disruption of the D2 dopamine receptor alters GH and IGF-I secretion and causes dwarfism in male mice. Endocrinology 143:1270-1279
18. Garcia-Tornadu I, Rubinstein M, Gaylinn BD, Hill D, Arany E, Low MJ, Diaz-Torga G, Becu-Villalobos D 2006 GH in the dwarf dopaminergic D2 receptor knockout mouse: somatotrope population, GH release, and responsiveness to GH-releasing factors and somatostatin. J Endocrinol 190:611-619
19. Wang GJ, Volkow ND, Logan J, Pappas NR, Wong CT, Zhu W, Netusil N, Fowler JS 2001 Brain dopamine and obesity. Lancet 357:354-357
20. Friedman E, Starr N, Gershon S 1973 Catecholamine synthesis and the regulation of food intake in the rat. Life Sci I 12:317-326
21. Levin P, Janda JK, Joseph JA, Ingram DK, Roth GS 1981 Dietary restriction retards the age-associated loss of rat striatal dopaminergic receptors. Science 214:561-562
22. Rojdmark S, Rossner S 1991 Decreased dopaminergic control of prolactin secretion in male obesity: normalization by fasting. Metabolism 40:191-195
23. Kok P, Roelfsema F, Langendonk JG, de Wit CC, Frolich M, Burggraaf J, Meinders AE, Pijl H 2006 Increased circadian prolactin release is blunted after body weight loss in obese premenopausal women. Am J Physiol Endocrinol Metab 290:E218-E224
24. Kok P, Roelfsema F, Frolich M, van Pelt J, Meinders AE, Pijl H 2006 Activation of dopamine D2 receptors lowers circadian leptin concentrations in obese women. J Clin Endocrinol Metab 91:3236-3240
25. Kok P, Roelfsema F, Frolich M, van Pelt J, Stokkel MP, Meinders AE, Pijl H 2006 Activation of dopamine D2 receptors simultaneously ameliorates various metabolic features of obese women. Am J Physiol Endocrinol Metab 291: E1038-E1043
26. Keenan DM, Takahashi PY, Liu PY, Roebuck PD, Nehra AX, Iranmanesh A, Veldhuis JD 2006 An ensemble model of the male gonadal axis: illustrative application in aging men. Endocrinology 147:2817-2828
27. Keenan DM, Chattopadhyay S, Veldhuis JD 2005 Composite model of time-varying appearance and disappearance of neurohormone pulse signals in blood. J Theor Biol 236:242-255
28. Akaike H 1974 A new look at the statistical model identification. IEEE Trans Autom Control AC 19:716-723
29. Keenan DM, Roelfsema F, Biermasz N, Veldhuis JD 2003 Physiological control of pituitary hormone secretory-burst mass, frequency, and waveform: a statistical formulation and analysis. Am J Physiol Regul Integr Comp Physiol 285:R664-R673
30. Pincus SM, Keefe DL 1992 Quantification of hormone pulsatility via an approximate entropy algorithm. Am J Physiol 262(5 Pt 1):E741-E754
31. Pincus S, Singer BH 1996 Randomness and degrees of irregularity. Proc Natl Acad Sci USA 93:2083-2088
32. Iranmanesh A, South S, Liem AY, Clemmons D, Thorner MO, Weltman A, Veldhuis JD 1998 Unequal impact of age, percentage body fat, and serum testosterone concentrations on the somatotrophic, IGF-I, and IGF-binding protein responses to a three-day intravenous growth hormone-releasing hormone pulsatile infusion in men. Eur J Endocrinol 139:59-71
33. Pincus SM 1991 Approximate entropy as a measure of system complexity. Proc Natl Acad Sci USA 88:2297-2301
34. Veldhuis JD, Straume M, Iranmanesh A, Mulligan T, Jaffe C, Barkan A, Johnson ML, Pincus S 2001 Secretory process regularity monitors neuroendocrine feedback and feedforward signaling strength in humans. Am J Physiol Regul Integr Comp Physiol 280:R721-R729
35. Roelfsema F, Biermasz NR, Veldman RG, Veldhuis JD, Frolich M, Stokvis-Brantsma WH, Wit JM 2001 Growth hormone (GH) secretion in patients with an inactivating defect of the GH-releasing hormone (GHRH) receptor is pulsatile: evidence for a role for non-GHRH inputs into the generation of GH pulses. J Clin Endocrinol Metab 86:2459-2464
36. Kok P, Buijs MM, Kok SW, Van Ierssel IH, Frolich M, Roelfsema F, Voshol PJ, Meinders AE, Pijl H 2004 Acipimox enhances spontaneous growth hormone secretion in obese women. Am J Physiol Regul Integr Comp Physiol 286:R693-R698
37. Chapman IM, Hartman ML, Straume M, Johnson ML, Veldhuis JD, Thorner MO 1994 Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than women. J Clin Endocrinol Metab 78:1312-1319
38. Ceda GP, Hoffman AR, Silverberg GD, Wilson DM, Rosenfeld RG 1985 Regulation of growth hormone release from cultured human pituitary adenomas by somatomedins and insulin. J Clin Endocrinol Metab 60:1204-1209
39. Carro E, Senaris R, Considine RV, Casanueva FF, Dieguez C 1997 Regulation of in vivo growth hormone secretion by leptin. Endocrinology 138:2203-2206
40. Bergendahl M, Evans WS, Pastor C, Patel A, Iranmanesh A, Veldhuis JD 1999 Short-term fasting suppresses leptin and (conversely) activates disorderly growth hormone secretion in midluteal phasewomen-aclinical research center study. J Clin Endocrinol Metab 84:883-894
41. Gravholt CH, Veldhuis JD, Christiansen JS 1998 Increased disorderliness and decreased mass and daily rate of endogenous growth hormone secretion in adult Turner syndrome: the impact of body composition, maximal oxygen uptake and treatment with sex hormones. Growth Horm IGF Res 8:289-298
42. Rosenbaum M, Fong YM, Hesse DG, Tracey KJ, Hintz RL, Lowry SF, Gertner JM 1989 Intravenous refeeding blocks growth hormone (GH)-provoked rises in serum free fatty acids and blunting of somatotroph response to GH-releasing hormone in normal men. J Clin Endocrinol Metab 69:310-316
43. Estienne MJ, Schillo KK, Green MA, Boling JA 1989 Free fatty acids suppress growth hormone, but not luteinizing hormone, secretion in sheep. Endocrinology 125:85-91
44. Imaki T, Shibasaki T, Shizume K, Masuda A, Hotta M, Kiyosawa Y, Jibiki K, Demura H, Tsushima T, Ling N 1985 The effect of free fatty acids on growth hormone (GH)-releasing hormone-mediated GH secretion in man. J Clin Endocrinol Metab 60:290-293
45. Pijl H 2003 Reduced dopaminergic tone in hypothalamic neural circuits: expression of a "thrifty" genotype underlying the metabolic syndrome? Eur J Pharmacol 480:125-131
46. Meier AH, Cincotta AH 1996 Circadian rhythms regulate the expression of the thrifty genotype/phenotype. Diabetes Rev 4:464-487
47. Cincotta AH, MacEachern TA, Meier AH 1993 Bromocriptine redirects metabolism and prevents seasonal onset of obese hyperinsulinemic state in Syrian hamsters. Am J Physiol 264(2 Pt 1):E285-E293
48. Cincotta AH, Meier AH 1995 Bromocriptine inhibits in vivo free fatty acid oxidation and hepatic glucose output in seasonally obese hamsters (Mesocricetus auratus). Metabolism 44:1349-1355
49. Cincotta AH, Schiller BC, Meier AH 1991 Bromocriptine inhibits the seasonally occurring obesity, hyperinsulinemia, insulin resistance, and impaired glucose tolerance in the Syrian hamster, Mesocricetus auratus. Metabolism 40: 639-644
50. Luo S, Meier AH, Cincotta AH 1998 Bromocriptine reduces obesity, glucose intolerance and extracellular monoamine metabolite levels in the ventromedial hypothalamus of Syrian hamsters. Neuroendocrinology 68:1-10
51. Luo S, Liang Y, Cincotta AH 1999 Intracerebroventricular administration of bromocriptine ameliorates the insulin-resistant/glucose- intolerant state in hamsters. Neuroendocrinology 69:160-166
52. Cincotta AH, Meier AH 1989 Reductions of body fat stores and total plasma cholesterol and triglyceride concentrations in several species by bromocriptine treatment. Life Sci 45:2247-2254
53. Cincotta AH, Tozzo E, Scislowski PW 1997 Bromocriptine/SKF38393 treatment ameliorates obesity and associated metabolic dysfunctions in obese (ob/ob) mice. Life Sci 61:951-956
54. Johannsson G, Marin P, Lonn L, Ottosson M, Stenlof K, Bjorntorp P, Sjostrom L, Bengtsson BA 1997 Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. J Clin Endocrinol Metab 82:727-734
55. Svensson J, Bengtsson BA, Taskinen MR, Wiklund O, Johannsson G 2000 A nine-month, placebo-controlled study of the effects of growth hormone treatment on lipoproteins and LDL size in abdominally obese men. Growth Horm IGF Res 10:118-126
56. Buijs MM, Burggraaf J, Langendonk JG, Schoemaker RC, Frolich M, Arndt JW, Cohen AF, Romijn JA, Ackermans MT, Sauerwein HP, Meinders AE, Pijl H 2002 Hyposomatotropism blunts lipolysis in abdominally obese women. J Clin Endocrinol Metab 87:3851-3858
57. Giustina A, Veldhuis JD 1998 Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 19:717-797
58. Johannsson G, Bengtsson BA 1999 Growth hormone and the metabolic syndrome. J Endocrinol Invest 22:41-46
59. Vanderschueren-Lodeweyckx M 1993 The effect of simple obesity on growth and growth hormone. Horm Res 40:23-30
60. Sato A, Shioda S, Nakai Y 1989 Catecholaminergic innervation of GRF-containing neurons in the rat hypothalamus revealed by electron-microscopic cytochemistry. Cell Tissue Res 258:31-34
61. Niimi M, Takahara J, Sato M, Kawanishi K 1992 Identification of dopamine and growth hormone-releasing factor-containing neurons projecting to the median eminence of the rat by combined retrograde tracing and immunohistochemistry. Neuroendocrinology 55:92-96
62. Zoli M, Agnati LF, Tinner B, Steinbusch HW, Fuxe K 1993 Distribution of dopamine-immunoreactive neurons and their relationships to transmitter and hypothalamic hormone-immunoreactive neuronal systems in the rat mediobasal hypothalamus. A morphometric and microdensitometric analysis. J Chem Neuroanat 6:293-310